Načítá se...

Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxia

The aim of this study was to investigate the effect of recombinant human endostatin (rh-Endo) in combination with radiation therapy (RT) on esophageal squamous cell carcinoma (ESCC) and explore the potential mechanisms. ECA109-bearing nude mice were administered RT and/or rh-Endo treatment. Tumor vo...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Sci Rep
Hlavní autoři: Zhu, Hongcheng, Yang, Xi, Ding, Yuqiong, Liu, Jia, Lu, Jing, Zhan, Liangliang, Qin, Qin, Zhang, Hao, Chen, Xiaochen, Yang, Yuehua, Yang, Yan, Liu, Zheming, Yang, Meiling, Zhou, Xifa, Cheng, Hongyan, Sun, Xinchen
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2015
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4585975/
https://ncbi.nlm.nih.gov/pubmed/26412785
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep14503
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!